Micronized Purified Flavonoid Fraction (MPFF)
Product Description
Sichuan New Hawk Biotechnology Co., Ltd.
-
Country/Region:China
-
Founded:1989
-
On CPHI since:2022
-
Certificates:3
-
Employees:50 - 99
Company types
Primary activities
Categories
Specifications
Sichuan New Hawk Biotechnology Co., Ltd.
-
Country/Region:China
-
Founded:1989
-
On CPHI since:2022
-
Certificates:3
-
Employees:50 - 99
Company types
Primary activities
More Products from Sichuan New Hawk Biotechnology Co., Ltd. (6)
-
Product Diosmin
地奥司明是一种毛细血管保护药物,用于治疗与静脉和淋巴功能不全相关的各种症状,如静脉水肿、麻木和肢体沉重,以及治疗急性痔疮发作的各种症状,如瘙痒、便血、疼痛等。 -
Product Diosmin+Hesperidin(Mixture)
It has a vitamin P-like effect, which can reduce the fragility of blood vessels and abnormal permeability, and is also used in the adjuvant treatment of preventing and treating hypertension and arteriosclerosis. It is used in the treatment of capillary fragility and has the characteristics of low toxicity.... -
Product Hesperidin
Hesperidin, a vitamin drug extracted from fructus aurantii, can reduce the brittleness and permeability of capillaries, and hesperidin can improve the reduced resistance of capillaries(enhance the effect of vitamin C). Studies have also shown that hesperidin has anti-inflammatory, antiviral, anc can preven... -
Product Micronized Purified Flavonoid Ffraction (MPFF)
It can also be used to assist in the treatment of diabetes, Alzheimer's disease, arthritis and other diseases. Flavonoids can improve wound microcirculation and promote wound healing. Reducing the oxidative stress response of diabetic patients, delaying the development of diabetes, and improving ... -
Product Micronized Purified Flavonoid Fraction (MPFF)
它由90%的二雄胺和10%的Hesperidin组成,具有保护血管的作用,提高静脉张力,从而增加淋巴回流并改善毛细血管的通透性。它常被临床用于治疗慢性静脉内脏(CVI)、静脉溃疡和痔疮。微粒化纯化类黄酮分馏成分还具有减少去甲肾上腺素、脑血流、降低毛细血管通透性、促进淋巴引流以及减少或阻断慢性炎症反应的优点。在临床实践中,微粒化纯化类黄酮分数是慢性静脉疾病(CVD)的重要治疗选择。作为一种静脉活性药物,纯化微粒化类黄酮成分已在欧洲、美国使用近60年,为全球近2500万静脉炎症患者带来了治疗益处。 -
Product Micronized Purified Flavonoid Fraction (MPFF)
它由90%的二雄胺和10%的Hesperidin组成,具有保护血管的作用,提高静脉张力,从而增加淋巴回流并改善毛细血管的通透性。它常被临床用于治疗慢性静脉内脏(CVI)、静脉溃疡和痔疮。微粒化纯化类黄酮分馏成分还具有减少去甲肾上腺素、脑血流、降低毛细血管通透性、促进淋巴引流以及减少或阻断慢性炎症反应的优点。在临床实践中,微粒化纯化类黄酮分数是慢性静脉疾病(CVD)的重要治疗选择。作为一种静脉活性药物,纯化微粒化类黄酮成分已在欧洲、美国使用近60年,为全球近2500万静脉炎症患者带来了治疗益处。
Sichuan New Hawk Biotechnology Co., Ltd. resources (3)
-
News We will attend CPHI Frankfurt from 28- 30, Oct, 2025
Welcome to meet us at CPHI Frankfurt!From 28-30, Oct, 2025. -
News We will attend CPHI Milan from 8-10, Oct, 2024
Time: 8-10, Oct, 2024
Add: Messe Milan Italy
Booth No: 4F2





